Find Academic Supervisors

• Micro-scale drug delivery
• 3-D printing of pharmaceuticals
• Microneedle transdermal systems
• +4 more

Associate Professor Lifeng Kang is a pharmaceutical scientist at the University of Sydney School of Pharmacy , Faculty of Medicine and Health. He leads the Kang Lab which develops micro-scale and 3-D-printing technologies for drug delivery and regenerative medicine, and teaches undergraduate and postgraduate pharmacy courses. Education & career: BSc & MSc – China Pharmaceutical University (Nanjing, China) PhD – National University of Singapore (2006, drug delivery) Post-doctoral fellow – Massachusetts Institute of Technology (2007-2009, NUS-OPF Fellowship) Lecturer & Programme Director – National University of Singapore (2009-2017) Lecturer → Senior Lecturer → Associate Professor – University of Sydney (2017-present) Visiting Scholar – Stanford University (2019) Research focus: Microfabricated drug-delivery systems, 3-D printing of personalised medicines, dissolvable and hydrogel-forming microneedles, transdermal vaccination and cosmeceuticals, silk-fibroin and peptide biomaterials, organoid models for toxicology, and machine-learning-guided formulation design. Publications & impact: 86 peer-reviewed articles (65 first/corresponding), >4,600 citations, H-index 40, listed in Stanford/Elsevier global top-2 % scientists 2022-2024. Recent work appears in Nature Nanotechnology , Advanced Drug Delivery Reviews , Journal of Controlled Release , Analytical Chemistry and Biomaterials Advances . Innovation & translation: 10 patent families (5 granted, 3 licensed to industry); doctoral students have spun out two start-ups in 3-D-printed pharmaceuticals and microneedle devices. Current grants target osteoarthritis pain, skin depigmentation, paediatric IV stability and needle-free vaccination. Leadership & service: Vice-Chair (ANZ) Dissolution Research Presentation International 2023; 2nd-Year BPharm Coordinator; editorial boards of Advanced Drug Delivery Reviews , Frontiers in Pharmacology , Journal of Pharmacy and Pharmacology , Nano Convergence and others; reviewer for 40+ journals. Teaching & supervision: 14 years’ experience, primary supervisor of 15 PhD/MPhil students and >50 honours/project students; teaches drug delivery, formulation science and pharmaceutical analysis; research interest in mastery learning and formative assessment.

Bahez GarebView profile

Assistant Professor

• Pharmaceutical Science
• Pharmacology
• Biotechnology
• +5 more

Dr. Bahez Gareb serves as an Assistant Professor at the Faculty of Medical Sciences, University of Groningen, and works as a Hospital Pharmacist at the University Medical Center Groningen (UMCG). His contact information includes telephone +31 50 361 7870 and email b.gareb01@umcg.nl. He maintains dual roles bridging academic research with clinical pharmacy practice, with particular focus on advanced therapy medicinal products and pharmaceutical compounding. Dr. Gareb's research expertise spans pharmaceutical science, biotechnology, and advanced therapy medicinal products (ATMPs), with special emphasis on chimeric antigen receptor (CAR) T cells, pharmaceutical compounding, and good manufacturing practices. His fingerprint analysis reveals significant contributions to Hospital Pharmacy (100%), Good Manufacturing Practice (47%), and inflammatory bowel disease treatment. His work directly addresses United Nations Sustainable Development Goals related to good health and well-being through innovations in drug development and quality control systems. His publication record shows consistent output with 18 research items including 12 articles, 2 book chapters, and other academic contributions. Recent work focuses on CAR-T cell quality control, clinical-grade cell therapy production, and targeted drug delivery systems. The trend indicates increasing specialization in advanced therapy medicinal products and point-of-care manufacturing approaches. Dr. Gareb actively contributes to professional development through multiple leadership roles: Member of the Cellular Therapy Facility Board at UMCG Member of NVZA Commission for Aseptic Handlings and Microbiology Board member of Dutch Immune Effector Cell working group (HOVON) Participant in Dutch ATMP working group Member of DARE-NL Member of training team for hospital pharmacists in training His academic service includes serving on PhD examination committees, guest editing for Pharmaceutics journal, and delivering invited presentations on CAR-T cell manufacturing. Media coverage of his work includes both professional research reporting and popular science articles about hospital cost savings through optimized pharmaceutical practices.

Miguel JimenezView profile

Assistant Professor

• Microbial devices
• Bioelectronic devices
• Synthetic biology
• +11 more

Miguel Jimenez, Ph.D., is an Assistant Professor in Biomedical Engineering at Boston University, with a joint appointment in Materials Science & Engineering. His research focuses on integrating living microorganisms into electronic and mechanical devices to create novel biosensors, bioactuators, and therapeutic platforms. He leads the Microbial Integration Group, exploring applications in healthcare, food security, and space exploration. Education: A.B., Chemistry and Chemical Biology, Harvard University Ph.D., Chemistry, Columbia University Research Interests: Jimenez develops microbial devices for diagnostics, therapeutics, and environmental monitoring. His work emphasizes synthetic biology, biomaterials, nanotechnology, and systems engineering. Key areas include in situ directed evolution, countermeasures for space travel, and smart probiotics for inflammatory bowel disease (IBD). Awards : 2022: Broad Institute’s Next Generation in Biomedicine 2019: NASA TRISH Postdoctoral Fellowship 2017: Academy of Bioastronautics Fellowship 2013: NSF Graduate Research Fellowship Labs & Affiliations : Jimenez collaborates across Boston University’s Biological Design Center, Nanotechnology Innovation Center (BUnano), and the Molecular Biology, Cell Biology, & Biochemistry program. His work bridges engineering, biology, and medicine to address global challenges in healthcare and sustainability.

• Materials Science
• Biomedical Engineering
• Drug Delivery Systems
• +3 more

Michael Cima is a Professor in the Department of Materials Science and Engineering at the Massachusetts Institute of Technology (MIT), within the College of Engineering. His research focuses on biomedical materials, implantable medical devices, and neural engineering. He specializes in developing innovative drug delivery systems, neural interfaces, and diagnostic sensors using advanced materials science principles. Notable projects include implantable sensors for tumor oxygenation monitoring, microinvasive neural probes, and portable MRI-based diagnostic tools for hydration assessment. His work integrates engineering, biology, and medicine to address challenges in chronic disease management, neurology, and oncology. Cima has contributed significantly to translational research, bridging laboratory innovations with clinical applications. His lab develops scalable carbon fiber electrode arrays and drug delivery microdevices for real-time neurochemical monitoring and localized therapy delivery. Cima's research also involves surface tension-assisted additive manufacturing techniques and biocompatible materials to improve implant longevity. His contributions have advanced the fields of biomedical engineering, materials science, and personalized medicine through interdisciplinary collaboration.

• Nanoparticle Drug Delivery Systems
• Stem Cell Biology
• Metabolomics
• +5 more

Mohammad Al-Natour, PhD is a Postdoctoral Research Scholar at the University of Iowa's College of Pharmacy, affiliated with the Department of Pharmaceutical Sciences and Experimental Therapeutics. His research focuses on nanoparticle design for drug delivery, stem cell biology, and metabolomics analysis in biomedical applications. Dr. Al-Natour holds a PhD in Pharmaceutical Sciences. His work integrates nanotechnology, biomaterials science, and analytical techniques like LC-MS/MS to investigate drug delivery mechanisms, cellular responses to nanoparticles, and metabolic pathways in disease models. His research interests include: Development of targeted nanomedicines for cancer therapy Stem cell interactions with engineered biomaterials Metabolomics-based evaluation of nanoparticle toxicity Optimization of polymer-based drug delivery systems Publications highlight trends in: Nanoparticle surface functionalization for targeted drug delivery Metabolomic profiling of cellular responses to therapeutics Biomaterial design for dental and regenerative medicine applications Preclinical evaluation of drug-nanoparticle interactions No scientific awards or grants are listed in his profile. His work contributes to advancing translational nanomedicine and drug delivery technologies.

• Drug Delivery Systems
• Biomaterials Engineering
• Tissue Regeneration
• +3 more

Katie Ryan is a Senior Lecturer in Pharmaceutics at the School of Pharmacy, University College Cork (UCC). She holds a BSc in Pharmacy from Trinity College Dublin (TCD) and a PhD in Pharmaceutics (TCD), with postgraduate qualifications in Quality Improvement (TCD) and Teaching & Learning (UCC). She is a member of the UK & Ireland Controlled Release Society, serving as its President (2017-2020). Education & Professional Roles: BSc (Pharmacy), Trinity College Dublin (2001) MSc (Pharmaceutics), Trinity College Dublin (2007) Postgraduate Diploma in Statistics (2004) MA in Teaching & Learning in Higher Education (UCC, 2010) Research Focus: Her work centers on biomaterial-driven drug delivery systems for ocular, orthopedic, and bone regeneration applications. Key areas include: Sustained drug release via PLGA and hydroxyapatite scaffolds S1P receptor modulation in bone and retinal regeneration Combination therapies for implant-associated infections Bioengineered models for drug screening in metastatic cancers Grants & Funding: PI/co-PI of projects totaling >€1.2M from SFI, Enterprise Ireland, and industry collaborations. Active in the SFI-funded SSPC Centre. Awards & Recognition: Aspiring Leaders Leadership Programme (UCC, 2021) Erasmus Staff Mobility Grants (2021, 2016, 2014, 2012, 2011) Best Oral Prize at Irish Pharmacology Association (2021) Teaching & Outreach: Develops critical thinking curricula for pharmacy students. Leads STEM engagement initiatives in Cork schools, including Visual Thinking Strategies workshops. Chairs UCC's School of Pharmacy Staff-Student Committee. Labs & Collaborations: Collaborates with Harvard University (Prof. David Mooney) and Tyndall National Institute (Prof. Martyn Pemble). Active in the COST Action IMPROVE network and serves on editorial boards for Journal of Pharmaceutical Sciences .

Ken DevineView profile

Researcher

• Pharmaceutical Science
• Drug Delivery Systems
• Nematology
• +3 more

Dr. Ken Devine is the Chief Technical Officer at the School of Pharmacy, University College Cork (UCC). His research focuses on pharmaceutical science, drug delivery systems, and nematology, with a particular emphasis on plant-nematode interactions and controlled release technologies. He has contributed to advancements in understanding hatching factors of potato cyst nematodes and developed novel drug delivery mechanisms using mesoporous silica systems. Dr. Devine’s work spans multiple disciplines, including chemical synthesis of anti-cancer agents and lipidic dispersions to modulate drug bioavailability. He has secured grants such as the Embark Initiative Basic Research Grant (€100,000) and contributed to interdisciplinary projects through collaborations with institutions like the Environmental Research Institute and the Analytical Biological Chemistry Research Facility. His publications highlight contributions to pharmaceutical analysis, biotechnology, and nematology, with recent work focusing on regulatory approvals for medical devices like glass microneedles. He actively engages in community outreach, promoting pharmacy education through school workshops. Dr. Devine is a member of professional societies including the European Society of Nematologists and the Association of Applied Biology, reflecting his dedication to advancing both fundamental and applied research in his fields.

Mandeep MarwahView profile

Lecturer

• Drug Delivery Systems
• Pharmaceutical Formulation Development
• Liposome Technology
• +7 more

Mandeep Marwah is a Lecturer in Translational Pharmaceutics at Aston University, affiliated with the Aston Medical School and the College of Health and Life Sciences. He is also part of the Aston Research Centre for Health in Ageing and the Research Centre for the Humanities. His primary research focuses on developing targeted drug delivery systems, particularly for maternal health conditions like Preeclampsia and oncology. He holds a PhD from Aston University (2018) in deformable liposomal formulations for skin cancer treatment and a PG Cert in Teaching in Higher Education (2017). Research Interests: Marwah's current work targets placenta-specific liposomes to deliver therapeutics for Preeclampsia, aiming to reduce maternal mortality. He also explores hydrogen sulfide-based therapies for neurological and metabolic disorders, emphasizing mitochondrial targeting and controlled-release systems. His interdisciplinary approach integrates nanotechnology, formulation science, and clinical translation. Publications: His recent work includes studies on mesoporous silica microparticles for drug delivery, AP39-loaded liposomes for neuroprotection, and hydrogen sulfide's role in mitochondrial dysfunction. He has contributed to understanding senescence in muscle cells and rare genetic disorders like homozygous delta-beta thalassemia. Affiliations & Labs: Marwah collaborates with institutions globally and is involved in research teams focused on aging health, drug delivery innovation, and biomedical applications. No scientific awards or current student advisees are listed in the provided data.

Kamal JonnalagaddaView profile

Professor

• Pharmaceutical Sciences
• Polymeric Biomaterials
• Drug Delivery Systems
• +3 more

Kamal Jonnalagadda is a Professor in the Department of Pharmaceutical Sciences. He holds a BPharm from Birla Institute of Technology (India) and a PhD from the University of Nebraska. His research focuses on polymeric biomaterials for pharmaceutical applications, including drug delivery systems and tissue engineering. Specific interests include solid dosage form design, biodegradable implants, and 3D bioprinting. He has contributed to advancements in nanotechnology-based drug delivery, such as lipid nanoparticles and mesoporous silica for enhancing drug solubility. Education: BPharm, Birla Institute of Technology (India) PhD, University of Nebraska Research Interests: Design and characterization of polymeric biomaterials Amorphous stabilization techniques for BCS Class II drugs 3D bioprinting for tissue regeneration Topical drug delivery systems for HIV prevention Hydrophobic ion pairing for injectable formulations His work spans both fundamental material science and translational applications in healthcare, with a focus on overcoming formulation challenges in macromolecular drug delivery. Recent efforts include developing dual-compartment topical inserts for HIV prevention and optimizing solid lipid nanoparticles for poorly soluble drugs. Labs/Teams: Research activities are conducted in a lab focused on advanced biomaterials, collaborating with interdisciplinary teams in pharmaceutical engineering and biomedical sciences.

• Antimicrobial Biofilms
• Plasma-Activated Water (PAW)
• Antimicrobial Resistance (AMR)
• +3 more

Heema Vyas is a Researcher at the University of Adelaide's Institute for Photonics and Advanced Sensing, previously serving as a Postdoctoral researcher at the University of Sydney (2021–2024). Her work focuses on combating antimicrobial resistance (AMR) via plasma-activated water (PAW), targeting biofilms across healthcare, food safety, and environmental contexts. She investigates PAW's mechanisms, including membrane disruption, reactive species accumulation, and transcriptomic responses in biofilms. Her interdisciplinary research bridges microbiology, chemical engineering, and plasma physics. Key contributions include demonstrating PAW's efficacy against chronic infection biofilms and revealing novel stress-response pathways in bacteria exposed to PAW. She advocates for inclusive academic practices, publishing on queer/trans-inclusive hiring and conference design. Her work emphasizes translational solutions to global health challenges posed by AMR.

Matthew WebberView profile

Associate Professor

• Supramolecular Biomaterials
• Smart Drug Delivery
• Bio-inspired Materials
• +7 more

Matthew Webber is an Associate Professor in the Department of Chemical and Biomolecular Engineering at the University of Notre Dame’s College of Engineering. He leads the Webber Lab, an interdisciplinary research group focused on supramolecular biomaterials and smart drug delivery systems. His work integrates principles of supramolecular chemistry and molecular engineering to develop responsive materials for healthcare applications. Education: Ph.D., Biomedical Engineering, Northwestern University, 2011 M.S., Biomedical Engineering, Northwestern University, 2009 B.S., Chemical Engineering, University of Notre Dame, 2006 Dr. Webber’s research focuses on supramolecular biomaterials, glucose-responsive drug delivery (especially for diabetes), bio-inspired materials, and dynamic hydrogels. His lab engineers modular, tunable materials using non-covalent and dynamic covalent interactions to create systems that respond to biological cues such as glucose levels or enzymatic activity. These innovations are applied to insulin and glucagon delivery, cancer immunotherapy, and diagnostic platforms. The 15 most recent publications highlight a strong trend in developing intelligent, stimuli-responsive biomaterials. Key themes include glucose-responsive hydrogels, supramolecular peptide systems, host-guest chemistry, and applications in diabetes management and cancer immunotherapy. The work spans from fundamental mechanistic studies to translational therapeutic formulations. Scientific Awards: Fellow of the American Institute for Medical and Biological Engineering (AIMBE) Senior Member of the National Academy of Inventors NSF CAREER Award (2020) NIH MIRA Award Dr. Webber has secured major research funding, including the NSF CAREER and NIH MIRA awards, supporting his work on dissipative non-equilibrium hydrogels and supramolecular drug delivery. He actively mentors students and collaborates across institutions and with industry to translate innovations into real-world solutions. His lab emphasizes interdisciplinary collaboration and translational impact. The Webber Lab develops advanced materials through molecular design, focusing on supramolecular interactions that enable dynamic, reconfigurable, and bioresponsive systems. The group leverages both synthetic and bio-inspired strategies to create next-generation therapeutics and diagnostics.

Yongsheng GaoView profile

Assistant Professor

• Polymeric biomaterials
• Drug delivery
• Tissue engineering
• +3 more

Yongsheng Gao is an Assistant Professor of Bioengineering at the Erik Jonsson School of Engineering and Computer Science, University of Texas at Dallas. His research focuses on developing polymeric biomaterials, drug delivery systems, and regenerative medicine solutions. He leads the Gao Lab, an interdisciplinary group creating material-based therapies for unmet medical needs, such as targeted drug delivery and tissue engineering. His work emphasizes engineering polymer structures to control biological responses, with a focus on translating innovations from lab to clinical settings. Education: PhD in Bioengineering, University College Dublin (2017) MEng in Materials Science, Harbin Institute of Technology (2013) BEng in Materials Science, Harbin Institute of Technology (2011) Research Interests: Dr. Gao’s lab explores biomaterials for cell surface engineering, drug delivery systems (e.g., PEGylated therapeutics), and regenerative approaches for traumatic injuries. Recent work includes macrophage-adhering gadolinium micropatches for MRI contrast and deep eutectic solvents for protein drug delivery. His innovations prioritize biocompatibility, controlled release, and clinical relevance. Labs/Teams: The Gao Lab collaborates across disciplines to advance biomaterials research. Projects include hydrogel design for arthritis treatment and erythrocyte-mediated chemotherapy. Follow updates on Twitter and LinkedIn .

Sergey KazakovView profile

Professor

• Physical Chemistry
• Biophysical Chemistry
• Hydrogel and Lipid Membrane Assembly
• +7 more

Sergey Kazakov is a Professor of Chemistry and Program Director of the Pharmaceutical Sciences Program at Pace University, within the Dyson College of Arts and Sciences. He is affiliated with the Chemistry/Physical Sciences department and maintains active research and teaching roles at both the Westchester and NYC campuses. His office is located in Dyson Hall, Costello House, and he can be reached at skazakov@pace.edu. Education: Doctor of Physical and Mathematical Sciences, Moscow State University, Russia (1998) Dr. Kazakov’s research focuses on advanced drug delivery systems, particularly hydrogel and lipid membrane assemblies such as lipobeads and microgels. His work integrates physical chemistry, biophysics, and nanotechnology to develop "smart" platforms for targeted chemotherapy with minimal side effects. He investigates the thermodynamics and kinetics of supramolecular self-organization, redox-responsive degradation, and controlled release mechanisms. His lab specializes in modeling natural biochemical reactors using artificial membrane/hydrogel systems. His recent publications highlight a strong trend in redox- and pH-responsive microgels and lipobeads, with a focus on real-time degradation monitoring via confocal microscopy, swelling dynamics, and applications in anticancer drug delivery. These studies emphasize stimuli-responsive behavior, biodegradability, and precise control over drug release kinetics. Scientific Awards and Honors: Marquis Who's Who Lifetime Achievement Award (2021) Dyson College Faculty Excellence in Scholarship Award (2010) Pace University Scholarly Research, Kenan Travel, and Presidential Release Time Awards (2003–2022) Dyson College Summer Research Awards (2004–2019) Pace Undergraduate Student Academic Conference Travel Fund (multiple years) Swedish Institute Scholarships (1999, 2000) Certificate for Mentoring, ACS Undergraduate Research Symposium (2019) Dr. Kazakov is a dedicated mentor who has supervised numerous undergraduate and graduate students, many of whom have co-authored publications and presented at national conferences. He has secured external funding from the National Science Foundation and the American Chemical Society. He actively serves on multiple university committees and has contributed to curriculum development, student advising, and program leadership. He is also a prolific reviewer for over 25 scientific journals, including Langmuir , ACS Nano , and Pharmaceutics . His research lab focuses on the development of lipobeads and degradable microgels for drug and gene delivery, supported by ongoing grants and interdisciplinary collaborations. The team uses advanced techniques such as confocal microscopy and spectroscopy to study mechanochemical responses in polymer networks.

• Food Science
• Food Engineering
• Biopolymers
• +7 more

Roxana Elena Gheorghiță serves as a Lecturer at Stefan cel Mare University of Suceava's Faculty of Medicine and Biological Sciences since 2021, following her University Assistant position at the Department of Health and Human Development (2020-2021). Her academic foundation includes a Doctorate in Materials Engineering (2019), Master's in Hygiene Management and Food Quality Control, and Bachelor's in Food Control and Expertise from Romanian institutions. Her educational background demonstrates progressive specialization: Bachelor: Food Science and Engineering, Dunărea de Jos University of Galați Master: Food Engineering, Stefan cel Mare University of Suceava Doctorate: Materials Engineering, Stefan cel Mare University of Suceava (2019) Gheorghiță's research integrates food science with biomedical applications, focusing on biopolymer development for edible packaging, food safety enhancement, and clinical solutions. Her work bridges green economy implementation through sustainable materials while addressing contemporary health challenges including SARS-CoV-2 sequencing and gut microbiota-diabetes interrelationships. This interdisciplinary approach spans food technology, microbiology, and public health domains with strong industrial applicability. Analysis of her 15 most recent publications reveals dominant trends in biopolymer innovation (73%), with significant emphasis on food packaging (40%), antimicrobial applications (27%), and clinical translation (20%). The research demonstrates consistent progression from fundamental material characterization (2022) toward complex biomedical implementations (2024), increasingly incorporating natural compounds like Moringa oleifera and essential oils while maintaining strong methodological rigor in material testing. Her project leadership includes the INnoMAT initiative for edible supplement packaging and contributions to SARS-CoV-2 genome sequencing (12Sol/2020), MatCARN biodegradable meat packaging, and microDIAB gut microbiota research. These efforts demonstrate substantial grant acquisition capability and cross-disciplinary collaboration across food science, virology, and metabolic disease fields. Gheorghiță teaches bacteriology, virology, parasitology, food hygiene, and scientific methodology while actively developing biodegradable materials through university research teams. Her current work focuses on translational applications of biopolymers in both industrial food systems and clinical settings, particularly wound dressings and drug delivery systems.

• Pharmacology
• Pharmacy
• Pharmaceutical Technology
• +3 more

Affiliated with the University of Santiago de Compostela , Juan Jose Lapido Sanisidro works in the field of Pharmacology, Pharmacy and Pharmaceutical Technology . His research focuses on dosage forms and drug release systems. Research interests span: Pharmaceutical formulation Drug delivery mechanisms Controlled release technologies Pharmaceutical process optimization Currently teaching in the 2025/2026 academic year, his work bridges pharmaceutical technology development with clinical applications.